Women Health Diagnostic Testing Market

Women’s Health Diagnostic Testing Market: Global Industry Analysis and Opportunity Assessment 2017-2027

  • Ongoing
  • April 2020
  • REP-GB-3204
Women Health Diagnostic Testing Market

  • US$5,000
  • US$7,500
  • US$10,000

This Women Health Diagnostic Testing market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Women Health Diagnostic Testing market.

Women’s Health diagnostic testing comprises of various testing and diagnostic procedures for ruling out fatal diseases such as breast cancer, cervical cancer, ovarian cancer, HPV, urinary tract infections and osteoporosis. Whereas some of the diagnostic procedures are used in prenatal screening and for evaluating pregnancy and fertility. These diagnostic tests also helps in diagnosing STDs (Sexually Transmitted Diseases) and infections. Women’s health diagnostic testing procedures are available in hospitals, clinics mainly obstetrics and gynaecology clinics, pathology laboratories and radiology centres. Also increasing number of companies are providing point of care testing devices and testing kits for home usage.

Women’s Health diagnostic testing Market: Drivers and Restraints

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Need granular data and specific insights that are hard to get?
Women’s health diagnostic testing market is growing, this is attributed to increasing prevalence of osteoarthritis, ovarian cancer, breast cancer and cervical cancer. Also the market is expected to expand with the fastest CAGR due to increasing number of prenatal screening tests and anti-natal ultrasound along with increasing product launch for point of care testing devices. Increasing sales test kits for home usage is also expected to drive the revenue growth of women’s health diagnostic testing market over the forecast period.  In addition to this, growing healthcare expenditure, and rising awareness and apprehension regarding various types of malignant tumors, infectious diseases, STDs also aids the growth of women’s health diagnostic testing market as increasing number of patients are opting for the diagnostic tests to rule the underlying cause of their symptoms. Also, availability of newer and advanced diagnostic systems along with increasing strategic partnerships among the diagnostic device manufacturing companies also drives the women’s health diagnostic testing market, giving enormous opportunities to the companies within this market. However cost of diagnostic testing procedures might hamper the revenue growth of women’s health diagnostic testing market over the forecast period

The Women’s Health diagnostic testing market is segment based on the application type and end user

Women’s health diagnostic testing market is segmented into following types:

 Women’s Health diagnostic testingMarket: Overview

Women’s Health diagnostic testing Market: Region-wise Outlook

Depending on geographic region, the women’s health diagnostic testing market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America is the largest regional market owing to high patient awareness levels regarding various diagnostic testing procedures for women, increasing healthcare expenditure, reimbursement options and relatively larger number of R&D exercises pertaining new product launch and marketing etc. these factors contribute for significant revenue generation for diagnostic testing devices from the region.

Women’s Health diagnostic testing Market: Key Players

Some players of women’s health diagnostic testing market includes GE Healthcare, Becton, Dickinson and Company, Koninklijke Philips N.V., PerkinElmer Inc., Abbott Laboratories, Quest Diagnostics Inc., Hologic, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche AG  whereas some regional players also have a significant presence in Women’s Health diagnostic testing market.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Women Health Diagnostic Testing Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

By Application Type

  • Cancer Screening
    • Breast Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Osteoporosis
    • Pregnancy test
    • Prenatal test
    • Infections
    • STD test
    • Gynecological test
    • Others

By End User

  • Hospitals
  • Clinics
    • Gynecology & Obstetrics Clinics
    • Orthopedic Clinics
  • Diagnostic Laboratories
    • Cancer diagnostic centers
    • Pathology Laboratories
    • Radiology Centers
  • Cancer Institutes

Women’s health diagnostic testing market is expected to grow at a significant rate, over the forecast period. The market is anticipated to perform well over the forecast period due to increasing number of patients suffering from osteoporosis. Also increasing prevalence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques leads to more women opting for diagnostic procedures.  Women’s health diagnostic testing market is expanding globally due to increasing distribution partnerships among diagnostic testing device manufactures. The women’s health diagnostic testing market is expected to grow with a fastest CAGR over the forecast period due to increasing number of people opting for endovenous laser ablation procedure for cosmetic purpose. Increasing competition among major companies in the market to develop advanced systems which provides increased precision and accuracy during treatment drives the Women’s Health diagnostic testing market towards the growth curve.

Women’s Health diagnostic testing Market: Region-wise Outlook

Asia Pacific is expected to grow at the fastest CAGR because of increasing prevalence of breast cancer in women. Also increase in geriatric population leads to more number of cases with osteoporosis is expected to boost the revenue growth of women’s health diagnostic testing market throughout the forecast period.

Women’s Health diagnostic testing Market: Key Players

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, BENELUX)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa)

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Women Health Diagnostic Testing Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Women Health Diagnostic Testing Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology